Targeting N6-methyladenosine reader YTHDF1 with siRNA boosts antitumor immunity in NASH-HCC by inhibiting EZH2-IL-6 axis. Wang L, Zhu L, Liang C, Huang X, et al. J Hepatol 2023;79:1185-1200.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wang L, Zhu L, Liang C, Huang X, et al. Targeting N6-methyladenosine reader YTHDF1 with siRNA boosts antitumor immunity in NASH-HCC by inhibiting EZH2-IL-6 axis. J Hepatol 2023;79:1185-1200.
PMID: 37459919